Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

Bibliographic Details
Main Authors: Zielinski, Christoph, Lang, Istvan, Beslija, Semir, Kahan, Zsuzsanna, Inbar, Moshe J, Stemmer, Salomon M, Anghel, Rodica, Vrbanec, Damir, Messinger, Diethelm, Brodowicz, Thomas
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815806/
id pubmed-4815806
recordtype oai_dc
spelling pubmed-48158062017-01-19 Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer Zielinski, Christoph Lang, Istvan Beslija, Semir Kahan, Zsuzsanna Inbar, Moshe J Stemmer, Salomon M Anghel, Rodica Vrbanec, Damir Messinger, Diethelm Brodowicz, Thomas Clinical Study Nature Publishing Group 2016-01-19 2015-12-10 /pmc/articles/PMC4815806/ /pubmed/26657657 http://dx.doi.org/10.1038/bjc.2015.419 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Zielinski, Christoph
Lang, Istvan
Beslija, Semir
Kahan, Zsuzsanna
Inbar, Moshe J
Stemmer, Salomon M
Anghel, Rodica
Vrbanec, Damir
Messinger, Diethelm
Brodowicz, Thomas
spellingShingle Zielinski, Christoph
Lang, Istvan
Beslija, Semir
Kahan, Zsuzsanna
Inbar, Moshe J
Stemmer, Salomon M
Anghel, Rodica
Vrbanec, Damir
Messinger, Diethelm
Brodowicz, Thomas
Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
author_facet Zielinski, Christoph
Lang, Istvan
Beslija, Semir
Kahan, Zsuzsanna
Inbar, Moshe J
Stemmer, Salomon M
Anghel, Rodica
Vrbanec, Damir
Messinger, Diethelm
Brodowicz, Thomas
author_sort Zielinski, Christoph
title Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
title_short Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
title_full Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
title_fullStr Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
title_full_unstemmed Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
title_sort predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for her2-negative metastatic breast cancer
description
publisher Nature Publishing Group
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815806/
_version_ 1613560433591975936

Similar Items